MRI Systems

MRI Contrast Agent Imager & Analyzer

$42,500.00

Preclinical MRI system combining quantitative T1/T2 relaxivity measurement with small animal imaging for contrast agent development and validation.

Key Specifications
Analysis ModeT1/T2 Relaxivity + MRI Imaging
Animal CompatibilityMouse, Small Rat
Magnet TypePermanent NdFeB
Automation Levelsemi-automated
BrandGreenwaves Scientific
SpeciesSmall Rat, Mouse
SKU:NMS-MRI-CAIA
Category:MRI Systems
Need Help? Visit our Support CenterKnowledge base, order lookup, and ticket support
Our Staff are PhD Scientists
Get expert guidance on this product
Louise Corscadden, PhD, Neuroscience
Louise Corscadden
PhD, Neuroscience
Schedule a Call Instead

The MRI Contrast Agent Imager & Analyzer is a dedicated preclinical instrument that combines MRI imaging with quantitative contrast agent analysis. This system provides both T1/T2 relaxivity measurements and in-vivo imaging validation in a single integrated platform, designed specifically for pharmaceutical and biomedical researchers developing new MRI contrast agents.

The instrument features a permanent rare-earth NdFeB magnet system that requires no maintenance, making it suitable for laboratories developing novel MRI contrast agents, characterizing nanoparticle-based contrast materials, and conducting pharmacokinetic imaging studies. The system supports both mouse and small rat imaging with integrated relaxometry capabilities for comprehensive contrast agent characterization.

How It Works

The system operates using magnetic resonance imaging principles combined with quantitative relaxometry analysis. The permanent NdFeB magnet creates a stable magnetic field that aligns hydrogen nuclei in tissues and contrast agent solutions. Radiofrequency pulses excite these nuclei, and the system measures T1 (longitudinal) and T2 (transverse) relaxation times as the nuclei return to equilibrium.

For contrast agent characterization, the instrument measures relaxivity values (r1 and r2) by comparing relaxation times of solutions with and without contrast agents at various concentrations. The integrated imaging capability allows visualization of contrast agent distribution in living animals, providing both quantitative relaxometry data and spatial distribution information in a single experimental session.

Features & Benefits

Dual T1/T2 relaxivity measurement capability
Enables comprehensive characterization of contrast agents through both longitudinal and transverse relaxation measurements in a single system.
Integrated small animal MRI imaging
Combines quantitative analysis with in-vivo validation, allowing researchers to correlate relaxivity measurements with actual imaging performance.
Permanent NdFeB magnet system
Provides stable magnetic field without ongoing maintenance requirements or cryogenic cooling, reducing operational complexity and costs.
Mouse and small rat compatibility
Accommodates the most commonly used preclinical models for contrast agent development and pharmacokinetic studies.
Contrast agent development focus
Specifically designed for pharmaceutical researchers developing novel contrast materials, with protocols optimized for agent characterization.
Nanoparticle characterization capability
Supports analysis of advanced contrast formulations including nanoparticle-based and targeted imaging agents.
Pharmacokinetic imaging support
Enables longitudinal studies of contrast agent biodistribution and clearance patterns in living animal models.
MRI Contrast Agent Imager & Analyzer
MRI Contrast Agent Imager & Analyzer
$42,500.00
Added to quoteView Quote